SCHEMBL16684305

SCHEMBL16684305

O=C(OCC1O[C@H](OC(=O)c2ccccc2)C(O)C1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.55
USP2 O75604 2/20 0.51
POLB P06746 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
LGALS9 O00182 1/20 0.50
LGALS1 P09382 1/20 0.50
LGALS3 P17931 1/20 0.50
LGALS7; LGALS7B P47929 1/20 0.50
PTPN2 P17706 1/20 0.49
PTPN11 Q06124 1/20 0.49
MAPK1 P28482 3/20 0.47
F11 P03951 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
TMPRSS2 O15393 1/20 0.47
PDE5A O76074 1/20 0.47
HMGCR P04035 1/20 0.47
CYP1A2 P05177 1/20 0.47
LCK P06239 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2934878 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL2257134 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL14571284 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL5379160 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL18574064 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL14602169 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL10062436 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL21007943 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL20693186 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A
SCHEMBL14477068 1.00 PTPN1 (0.55) PTPN1USP2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332952-B1 Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections IDENIX PHARMACEUTICALS INC (US) 2015-04-29 EP disclosed